We are live on ! Find out more
ACGN

Aceragen Inc

Delisted

ACGN was delisted on the 21st of August, 2023.

50 hedge funds and large institutions have $27.3M invested in Aceragen Inc in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less capital invested

Capital invested by funds: $27.8M → $27.3M (-$516K)

11% less funds holding

Funds holding: 5650 (-6)

57% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 21

57% less call options, than puts

Call options by funds: $72K | Put options by funds: $168K

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

Holders
50
Holders Change
-6
Holders Change %
-10.71%
% of All Funds
1.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
9
Reduced
21
Closed
10
Calls
$72K
Puts
$168K
Net Calls
-$96K
Net Calls Change
+$47K

ACGN Hedge Fund Activity: Q3 2019 in Review

50 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Aceragen Inc (ACGN) for Q3 2019, worth a combined $27.3M — down 1.9% from $27.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ACGN and 4 opened new positions — a net loss of 6 holders — while 21 trimmed existing stakes and 9 added.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $357K. The largest seller was Natixis, exiting entirely with an estimated $1.99M sold.

  • 50 institutional investors held Aceragen Inc (ACGN) as of Q3 2019, down from 56 in Q2 2019.
  • Funds reported $27.3M of Aceragen Inc stock for Q3 2019, down 1.9% quarter-over-quarter.
  • 4 funds opened new Aceragen Inc positions in Q3 2019 and 10 closed out, a net change of -6 holders.
  • The largest Aceragen Inc buyer in Q3 2019 was JP Morgan Chase, an estimated $357K added.
  • The largest Aceragen Inc seller in Q3 2019 was Natixis, an estimated $1.99M sold.

Based on aggregated 13F filings for Q3 2019.